News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|August 2, 2015

Logistics, Appointments, and Clinical Trials

Episodes in this series

EP. 1 Being Diagnosed With Cancer

EP. 1 Being Diagnosed With Cancer

EP. 2 Talking to Your Doctor About Your Diagnosis

EP. 2 Talking to Your Doctor About Your Diagnosis

EP. 3 Learning About Your Prognosis

EP. 3 Learning About Your Prognosis

EP. 4 Cancer and Family Matters

EP. 4 Cancer and Family Matters

EP. 5 Myths About Cancer and Treatment

EP. 5 Myths About Cancer and Treatment

EP. 6 Logistics, Appointments, and Clinical Trials

EP. 6 Logistics, Appointments, and Clinical Trials

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of man

A Father’s Mission to Provide Relief for Kids with Blood Cancer

ByJoe McDonough

December 28th 2025

Myelofibrosis Survivor Reflects on the Impact of Her Physician

Myelofibrosis Survivor Reflects on the Impact of Her Physician

ByMayra Andujar-Delgado

December 28th 2025

Oya Gilbert

Advice for Patients Newly Diagnosed With Multiple Myeloma

December 27th 2025

image of man.

A Five-Time Cancer Survivor’s Advice for Patients

December 27th 2025

Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER+/HER2– breast cancer: © stock.adobe.com.

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

ByCourtney Flaherty

December 26th 2025

Trending on CURE

Advice for Patients Newly Diagnosed With Multiple Myeloma

A Five-Time Cancer Survivor’s Advice for Patients

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

Myelofibrosis Survivor Reflects on the Impact of Her Physician

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer